Literature DB >> 9987638

Acute hemodynamic and coronary circulatory effects of experimental autoimmune myocarditis.

B J Friedman1, O Y Grinberg, N R Ratcliffe, H M Swartz, W F Hickey.   

Abstract

Myocarditis and progression to cardiomyopathy is associated with focal spasm and reperfusion of the coronary microcirculation. Experimental autoimmune myocarditis (EAM), induced with cardiomyosin peptide-specific T cells in Lewis rats, was hypothesized to cause acute hemodynamic and coronary vasculature changes. Fifteen experimental animals (5 each at 1, 2, and 3 weeks after T-cell injection) and eight controls were studied using the constant pressure variant of the isolated heart. Coronary resistant decreased while coronary flow increased (P < 0.05) in EAM hearts after the first week. Rate-pressure product, +dP/dt and -dP/dt, decreased while the heart/body weight ratio increased (P < 0.05) compared with controls at 1 week but not at 2 or 3 weeks. Mean local myocardial PO2, which reflects local oxygen delivery and consumption, and MVO2 were not different for EAM hearts. However, compared with controls EAM myocardial PO2 varied more widely and was often beyond the usual range, suggesting the occurrence of localized hypoxic and hyperoxic areas. In summary, after the first week there was a significant decrease in coronary resistance in the EAM animals, which required higher flow to maintain a similar perfusion pressure. These changes in coronary resistance and flow along with the heterogeneity and extremes of local myocardial PO2 levels without a significant change in MVO2 may be explained by postulating development of low-resistance, high-flow hyperoxic areas which steal flow, thus causing hypoxia in other areas.

Entities:  

Mesh:

Year:  1998        PMID: 9987638     DOI: 10.1007/bf01744587

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  18 in total

Review 1.  The L-arginine-nitric oxide pathway.

Authors:  S Moncada; A Higgs
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

2.  Coronary reserve and contractile reserve in crystalloid- and blood-perfused rabbit hearts.

Authors:  M Masuda; C Chang-Chun; B C Cho; W Flameng
Journal:  Heart Vessels       Date:  1994       Impact factor: 2.037

3.  A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction.

Authors:  M Kodama; Y Matsumoto; M Fujiwara; F Masani; T Izumi; A Shibata
Journal:  Clin Immunol Immunopathol       Date:  1990-11

4.  Experimental influenza A virus myocarditis in mice. Light and electron microscopic, virologic, and hemodynamic study.

Authors:  M Kotaka; Y Kitaura; H Deguchi; K Kawamura
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

5.  Verapamil ameliorates the clinical and pathological course of murine myocarditis.

Authors:  R Dong; P Liu; L Wee; J Butany; M J Sole
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

6.  Effect of acute edema on left ventricular function and coronary vascular resistance in the isolated rat heart.

Authors:  A Rubboli; P A Sobotka; D E Euler
Journal:  Am J Physiol       Date:  1994-09

7.  Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis.

Authors:  S M Factor; T Minase; S Cho; R Dominitz; E H Sonnenblick
Journal:  Circulation       Date:  1982-08       Impact factor: 29.690

8.  Identification of myocarditogenic peptides derived from cardiac myosin capable of inducing experimental allergic myocarditis in the Lewis rat. The utility of a class II binding motif in selecting self-reactive peptides.

Authors:  K W Wegmann; W Zhao; A C Griffin; W F Hickey
Journal:  J Immunol       Date:  1994-07-15       Impact factor: 5.422

9.  Ischemic areas in perfused rat hearts: measurement by NADH fluorescence photography.

Authors:  C H Barlow; B Chance
Journal:  Science       Date:  1976-09-03       Impact factor: 47.728

10.  Inhomogenous capillary flow and its prevention by verapamil and hydralazine in the cardiomyopathic Syrian hamster.

Authors:  H R Figulla; F Vetterlein; M Glaubitz; H Kreuzer
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

View more
  1 in total

1.  Increases in circulating T lymphocytes expressing HLA-DR and CD40 ligand in patients with dilated cardiomyopathy.

Authors:  Atsuko Ueno; Kagari Murasaki; Nobuhisa Hagiwara; Hiroshi Kasanuki
Journal:  Heart Vessels       Date:  2007-09-20       Impact factor: 2.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.